Does SOTORASIB Cause Respiratory failure? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Respiratory failure have been filed in association with SOTORASIB (LUMAKRAS). This represents 0.3% of all adverse event reports for SOTORASIB.
9
Reports of Respiratory failure with SOTORASIB
0.3%
of all SOTORASIB reports
7
Deaths
5
Hospitalizations
How Dangerous Is Respiratory failure From SOTORASIB?
Of the 9 reports, 7 (77.8%) resulted in death, 5 (55.6%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Respiratory failure Listed in the Official Label?
Yes, Respiratory failure is listed as a known adverse reaction in the official FDA drug label for SOTORASIB.
What Other Side Effects Does SOTORASIB Cause?
Non-small cell lung cancer (483)
Death (319)
Disease progression (314)
Diarrhoea (284)
Off label use (193)
Nausea (98)
Non-small cell lung cancer metastatic (93)
Hepatotoxicity (91)
Fatigue (87)
Hepatic function abnormal (80)
What Other Drugs Cause Respiratory failure?
PREDNISONE (2,299)
CYCLOPHOSPHAMIDE (2,096)
RITUXIMAB (1,838)
TACROLIMUS (1,758)
METHOTREXATE (1,685)
DEXAMETHASONE (1,603)
MYCOPHENOLATE MOFETIL (1,469)
METHYLPREDNISOLONE (1,442)
PREDNISOLONE (1,346)
VINCRISTINE (1,120)
Which SOTORASIB Alternatives Have Lower Respiratory failure Risk?
SOTORASIB vs SOTROVIMAB
SOTORASIB vs SOVALDI
SOTORASIB vs SOYBEAN OIL
SOTORASIB vs SPARSENTAN
SOTORASIB vs SPARTALIZUMAB